At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
anti-static then static +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm
In Brief
A clinical study evaluating anti-static then static and Static then anti-static chamber for Asthma. Completed, enrolled 88 participants across 1 site.
Detailed Summary
Delivery of HFA albuterol through an antistatic valved holding chamber (VHC) will improve bronchodilator response during nocturnal bronchospasm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsChildren's Miracle Network
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2008
Primary CompletionApr 2009
Study CompletionMar 2010
First PostedApr 2010
TodayJul 2026
First PostedApr 27, 2010
Enrollment StartMay 1, 2008
Primary CompletionApr 1, 2009
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.2 years ago
Interventions
anti-static then staticdevice
Albuterol using static chambers
Static then anti-static chamberdevice
albuterol with Static then anti-static chambers